Trends and socioeconomic disparities in diabetes prevalence and quality of care among Israeli children; 2011-2018

Table 2 Prevalence of diabetes, diabetes clinic visits, HbA1c testing and HbA1c over 9% by SEP and age, 2018

	Total	SEP 1	SEP 2	SEP 3	SEP 4	OR^* (linear trend)	P-value (trend)
	Total	%	%	%	%	OR^* (linear trend)	P-value (trend)
Diabetes Prevalence
Age groups
2–9	0.05	0.04	0.05	0.04	0.06	1.05	0.198
10–14	0.18	0.17	0.18	0.18	0.18	1.02	0.409
15–17	0.28	0.24	0.30	0.29	0.32	1.04	0.004
Total (n = 2,267,785)	0.13	0.12	0.13	0.12	0.14	1.04	0.045
Diabetes clinic visits
Age groups
2–9	90.89	91.10	89.27	91.19	92.16	1.06	0.674
10–14	86.48	83.48	87.39	87.47	90.67	1.21	0.023
15–17	84.86	78.23	84.26	85.71	94.48	1.47	< 0.001
Total (n = 3019)	86.78	83.07	86.59	87.56	92.36	1.28	< 0.001
HbA1c testing
Age groups
2–9	71.06	80.82	70.06	65.41	60.78	0.73	< 0.001
10–14	77.20	81.08	81.09	72.70	67.88	0.77	< 0.001
15–17	81.26	85.61	83.02	79.59	72.39	0.77	< 0.001
Total (n = 3019)	77.44	82.67	79.53	73.77	67.90	0.76	< 0.001
HbA1c over 9%
Age groups
2–9	24.49	38.14	26.61	11.54	6.45	0.48	< 0.001
10–14	38.94	53.33	40.99	26.05	19.08	0.57	< 0.001
15–17	33.26	41.81	36.80	26.07	14.41	0.65	< 0.001
Total (n = 2338)	34.05	46.13	36.69	23.54	14.79	0.59	< 0.001

^*We used univariable logistic regression to assess whether the association between prevalence of diabetes, diabetes clinic visits, HbA1C testing and HbA1C over 9%, and SEP (as a continuous variable) displayed a linear trend. OR reflects a one-unit change in SEP. Results in bold indicate statistical significance at the 0.05 level

ISSN: 2045-4015